Epidermal growth factor receptor tyrosine kinase inhibitors combined with thoracic radiotherapy or chemoradiotherapy for advanced or metastatic non-small cell lung cancer: A systematic review and meta-analysis of single-arm trials

BACKGROUND: Preclinical in vitro experiments demonstrated that epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) might have synergistic effect in combination with radiotherapy on Non-small cell lung cancer (NSCLC), but the clinical trials showed inconsistence results in NSCLC...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ruifeng, Wei, Shihong, Zhang, Qiuning, Zhang, Xueliang, Luo, Hongtao, Tian, Jinhui, Li, Yi, Ge, Long, Wang, Xiaohu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708798/
https://www.ncbi.nlm.nih.gov/pubmed/31335695
http://dx.doi.org/10.1097/MD.0000000000016427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708798/
https://www.ncbi.nlm.nih.gov/pubmed/31335695
http://dx.doi.org/10.1097/MD.0000000000016427

Ejemplares similares